This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Foscavir (Foscarnet) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (37)
Death (20)
Life Threatening Events (12)
Disability (3)
Reports by Reaction Type
Renal Failure Acute (7),
Multi-Organ Failure (6),
Pancytopenia (6),
Renal Impairment (6),
Anaemia (5),
Septic Shock (5),
Toxic Epidermal Necrolysis (4),
Encephalitis Cytomegalovirus (4),
Cytomegalovirus Infection (4),
Hepatic Function Abnormal (3),
Pyrexia (3),
Pneumonia Cytomegaloviral (3)
Below are a few examples of reports where side effects / adverse reactions may be related to Foscavir (Foscarnet). For a complete list or a specific selection of reports, please use the links above.
Possible Foscavir side effects in 40 year old female
Reported by a individual with unspecified qualification from Italy on 2012-08-08
Patient: 40 year old female
Reactions: Multi-Organ Failure, Continuous Haemodiafiltration, Septic Shock, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Rapamune(rapamune); Myfortic(myfortic); Levofloxacina(levofloxacina); Fludarabine Phosphate; Vfend; Treosulfan(treosulfan); Mabthera; Bactrim; ATG-Fresenius(atg-Fresenius); Urbason(urbason)
Possible Foscavir side effects in 64 year old female
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: 64 year old female
Reactions: Retinal Detachment, Vitreous Haemorrhage, Visual Acuity Reduced, Retinal Ischaemia
Drug(s) suspected as cause:
Foscavir
Dosage: -1.00 times per-3.0days ophthalmic
Indication: Herpes Simplex
Valaciclovir
Dosage: -3.00 times per-1.odays oral
Administration route: Oral
Indication: Herpes Simplex
Other drugs received by patient: Bactrim; Prednisone TAB
Possible Foscavir side effects in 51 year old male
Reported by a individual with unspecified qualification from Japan on 2012-08-08
Patient: 51 year old male
Reactions: Renal Impairment, Fungal Test Positive, Dialysis, Pulmonary Alveolar Haemorrhage, Genital Ulceration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Possible Foscavir side effects in female
Reported by a physician from Italy on 2012-08-07
Patient: female
Reactions: Death, Multi-Organ Failure, Septic Shock, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Levofloxacin; Mabthera; Vfend; Treosulfano; Anti-Thymocyte Globulin NOS; Rapamune; Methylprednisolone; Bactrim; Myfortic; Fludarabine Phosphate
Possible Foscavir side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-27
Patient: female
Reactions: Death, Multi-Organ Failure, Septic Shock, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Myfortic; Levofloxacin; Anti-Thymocyte Globulin NOS; Rapamune; Treosulfano; Fludarabine Phosphate; Mabthera; Methylprednisolone; Bactrim; Vfend
Possible Foscavir side effects in 27 year old female
Reported by a individual with unspecified qualification from France on 2012-07-17
Patient: 27 year old female
Reactions: Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Dosage: intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-10
End date: 2012-02-10
Cancidas
Dosage: 70.00 mg
Indication: Candidiasis
Start date: 2012-02-10
End date: 2012-02-10
Other drugs received by patient: Gaviscon; Truvada; Lederfoline( Lederfoline); Raltegravir (Raltegravir); Inexium (Inexium); Fluconazole; Diffu K (Diffu K); Bactrim; Primperan (Primperan); Rovalcyte (Rovalcyte)
Possible Foscavir side effects in female
Reported by a physician from Japan on 2012-06-06
Patient: female, weighing 53.5 kg (117.7 pounds)
Reactions: Oligohydramnios, Renal Impairment, Maternal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Indication: Cytomegalovirus Enterocolitis
Candesartan Cilexetil
Dosage: 4 mg, uid/qd
Administration route: Oral
Indication: Renal Disorder
Start date: 2010-01-04
End date: 2010-12-16
Prograf
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Other drugs received by patient: Candesartan Cilexetil; Cotrim
Possible Foscavir side effects in 26 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-11
Patient: 26 year old female
Reactions: Hypersensitivity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Start date: 2012-02-10
End date: 2012-02-10
Foscavir
Start date: 2012-02-10
End date: 2012-02-10
Possible Foscavir side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-09
Patient: 55 year old male
Reactions: Confusional State, Sensory Loss, Muscular Weakness, Paraesthesia, Cytomegalovirus Myelomeningoradiculitis, Encephalitis Cytomegalovirus, Quadriparesis, Hyporeflexia, Urinary Retention
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Immunoglobulin G; Thiotepa; Fludarabine Phosphate; Antithymocyte-Globuline ATG / Rabbit Anti-Human Thymocyte Immunoglobulin; Immunoglobulin A / Immunoglobulins; Melphalan Hydrochloride
Possible Foscavir side effects in 25 year old male
Reported by a consumer/non-health professional from Japan on 2012-04-23
Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Itraconazole
Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-06-06
End date: 2009-07-16
Foscavir
Dosage: form:inj1 df= 10 unit nos
Start date: 2009-07-10
End date: 2009-07-16
Bactrim
Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
Administration route: Oral
Indication: Antibiotic Prophylaxis
Start date: 2009-04-14
End date: 2009-07-16
Farom
Administration route: Oral
Start date: 2009-04-28
End date: 2009-05-01
Neoral
Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
Administration route: Oral
Indication: Prophylaxis
Start date: 2009-04-14
End date: 2009-07-08
Sprycel
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-16
End date: 2009-07-08
Maxipime
Start date: 2009-04-24
End date: 2009-04-27
Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone
Possible Foscavir side effects in female
Reported by a individual with unspecified qualification from United Kingdom on 2012-04-10
Patient: female, weighing 20.0 kg (44.0 pounds)
Reactions: Hypertensive Encephalopathy, Electroencephalogram Abnormal, Posterior Reversible Encephalopathy Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Foscavir
Dosage: 2400, mg milligram(s), 1, 1, days intravenous (not otherwise specified)
Start date: 2012-01-16
End date: 2012-01-25
Cyclosporine
Dosage: 1.45, mg/kg milligram(s)/kilogram intravenous (not otherwise specified)
Indication: Prophylaxis Against Transplant Rejection
Start date: 2011-12-15
End date: 2012-01-24
Meropenem
Dosage: 1200, mg milligram(s), 1, 1, days intravenous (not otherwise specified)
Targocid
Dosage: 200, mg milligram(s), 1, 1, days intravenous (not otherwise specified)
Other drugs received by patient: Leflunomide: Oral / Leflunomide; Vfend: Intravenous (Not Otherwise Specified) / Voriconazole; Filgrastim: Intravenous (Not Otherwise Specified) / Filgrastim
Possible Foscavir side effects in 46 year old male
Reported by a individual with unspecified qualification from France on 2012-03-09
Patient: 46 year old male
Reactions: Renal Tubular Disorder, Renal Impairment, Scrotal Ulcer, Proteinuria, Haematuria, Toxicity To Various Agents, Chemical Injury
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Orbenine / Cloxacillin Sodium Monohydrate; Aransep / Darbepoetin Alfa; Calcidia / Calcium Carbonate
Possible Foscavir side effects in female
Reported by a physician from France on 2012-03-09
Patient: female, weighing 20.0 kg (44.0 pounds)
Reactions: Posterior Reversible Encephalopathy Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Meropenem
Start date: 2012-01-13
End date: 2012-01-21
Targocid
Start date: 2012-01-13
End date: 2012-01-21
Cyclosporine
Indication: Prophylaxis Against Transplant Rejection
Start date: 2011-12-15
End date: 2012-01-24
Foscavir
Start date: 2012-01-16
End date: 2012-01-25
Other drugs received by patient: Filgrastim; Leflunomide; Vfend
Possible Foscavir side effects in female
Reported by a physician from Japan on 2012-03-07
Patient: female, weighing 53.5 kg (117.7 pounds)
Reactions: Oligohydramnios, Renal Impairment, Maternal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prograf
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Foscavir
Indication: Cytomegalovirus Enterocolitis
Candesartan Cilexetil
Dosage: 4 mg, uid/qd
Administration route: Oral
Indication: Renal Disorder
Start date: 2010-01-04
End date: 2010-12-16
Other drugs received by patient: Cotrim; Candesartan Cilexetil
Possible Foscavir side effects in 9 year old female
Reported by a physician from Japan on 2012-03-07
Patient: 9 year old female
Reactions: Ventricular Extrasystoles, Blood Bilirubin Increased, Weight Increased, Haemoglobin Decreased, Renal Failure, Respiratory Failure, Dialysis, Blood Potassium Decreased, Pulmonary Congestion, Pleural Effusion, Platelet Count Decreased, Neuroblastoma Recurrent, Pulmonary Oedema, Cardiac Arrest
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Foscavir
Dosage: parenteral
Indication: Cytomegalovirus Infection
Start date: 2008-04-15
End date: 2008-04-22
Targpocid (Teicoplanin)
Dosage: parenteral
Indication: Infection
Start date: 2008-04-20
End date: 2008-04-25
Prograf
Dosage: 0.1 mg, unknown/d, parenteral
Indication: Graft Versus Host Disease
End date: 2008-04-27
Ambisome
Dosage: 49.2 mg, uid/qd, parenteral; 50 mg, uid/qd, parenteral
Indication: Pyelonephritis Fungal
Start date: 2008-04-23
End date: 2008-04-25
Ambisome
Dosage: 49.2 mg, uid/qd, parenteral; 50 mg, uid/qd, parenteral
Indication: Pyelonephritis Fungal
Start date: 2008-04-09
End date: 2008-04-22
Neutrogin (Lenograstim)
Dosage: 100 ug, uid/qd, iv nos; dr, parenteral
Indication: Neutropenia
Start date: 2008-04-15
End date: 2008-04-26
Neutrogin (Lenograstim)
Dosage: 100 ug, uid/qd, iv nos; dr, parenteral
Indication: Neutropenia
Start date: 2008-04-27
End date: 2008-04-30
Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
Dosage: iv nos; iv nos; iv nos
Indication: Viral Infection
Start date: 2008-05-06
End date: 2008-05-06
Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
Dosage: iv nos; iv nos; iv nos
Indication: Viral Infection
Start date: 2008-04-23
End date: 2008-04-23
Anitvirals FOR Systemic USE (Antivirals FOR Systemic Use)
Dosage: iv nos; iv nos; iv nos
Indication: Viral Infection
Start date: 2008-05-10
End date: 2008-05-10
Other drugs received by patient: Vfend; Solu-Medrol; Nicardipine Hydrochloride; Sodium Chloride 0.9%; Atraxa-P (Hydroxyzine Hydrochloride); Capillary Stablizing Agents; Amoban (Zopiclone); Elemenmic (Minerals Nos); Potassium Chloride; Omepral (Omperazole); Morphine Hydrochloride (Morphine Hydrochloride); Urso (Ursodexoycholic Acid); Dopamine Hydrochloride; Firstcin (Cefozopran Hydrochloride); Fulcaliq 2; Novo Heparin Calcium (Heparin Calcium); Sulfamethoxazole and Trimethoprim; Alprostadil; Albumin (Human)
Possible Foscavir side effects in female
Reported by a physician from Japan on 2012-03-05
Patient: female, weighing 53.5 kg (117.7 pounds)
Reactions: Renal Impairment, Maternal Exposure During Pregnancy, Polyhydramnios
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Indication: Cytomegalovirus Enterocolitis
Prograf
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Candesartan Cilexetil
Dosage: 4 mg, uid/qd
Administration route: Oral
Indication: Renal Disorder
Start date: 2010-01-04
End date: 2010-12-16
Other drugs received by patient: Cotrim; Candesartan Cilexetil
Possible Foscavir side effects in 46 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28
Patient: 46 year old male
Reactions: Renal Tubular Disorder, Scrotal Ulcer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Foscavir
Other drugs received by patient: Calcidia; Orbenin CAP; Aranesp
Possible Foscavir side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24
Patient: 69 year old female
Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Lactic Acidosis, Pyrexia, Liver Disorder, Epstein-Barr Virus Infection, Multi-Organ Failure, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
Dosage: 3.5 mg/kg for five days
Indication: Aplastic Anaemia
Start date: 2010-09-15
Foscavir
Dosage: unk ukn, unk
Neoral
Dosage: 200 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2010-05-01
Other drugs received by patient: Neupogen; Blood and Related Products; Primobolan-Depot INJ
Possible Foscavir side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24
Patient: 28 year old female
Reactions: Encephalitis Cytomegalovirus, Renal Failure, Oliguria, Oedema Peripheral, Cytomegalovirus Viraemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mycophenolate Mofetil
Dosage: 2000 mg/day from day 1 before second cbt
Administration route: Oral
Indication: Prophylaxis Against Graft Versus Host Disease
Foscavir
Start date: 2011-06-03
Anti-Thymocyte Globulin NOS
Dosage: 2.5 mg/kg starting on day -4 during third cbt
Fludarabine Phosphate
Dosage: 25 mg/m2 starting on day -7 during second cbt
Foscavir
Start date: 2011-04-20
Cyclophosphamide
Dosage: 60 mg/kg on day-7 and -6 during third cbt
Cyclosporine
Dosage: 3 mg/kg/day starting from day 1 before the third cbt
Indication: Prophylaxis Against Graft Versus Host Disease
Foscavir
Indication: Encephalitis Cytomegalovirus
Busulfan
Dosage: 4 mg/kg starting on day -7 during second cbt
Methotrexate
Dosage: 2000 mg/day from day 1 before second cbt
Indication: Prophylaxis Against Graft Versus Host Disease
Methylprednisolone
Dosage: 80 mg/day on day -3 during third cbt
TBI / TLI
Dosage: 7.25 gy, day -1 during third cbt
Tacrolimus
Dosage: 0.2 mg/kg/day from day 1 before second cbt
Indication: Prophylaxis Against Graft Versus Host Disease
Cyclophosphamide
Dosage: 50 mg/kg on day-3 and -2 during first cbt
TBI / TLI
Dosage: 12 gy/6 fractions on day -7. -6 and -4 during first cbt
Methylprednisolone
Dosage: 40 mg/day on day -4 during third cbt
Possible Foscavir side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-23
Patient: 28 year old female
Reactions: Encephalitis Cytomegalovirus, Pathogen Resistance
Adverse event resulted in: death
Drug(s) suspected as cause:
Foscavir
Dosage: ssee image
Indication: Encephalitis Cytomegalovirus
Start date: 2011-04-20
Foscavir
Dosage: ssee image
Indication: Encephalitis Cytomegalovirus
Start date: 2011-03-06
Foscavir
Dosage: 90, mg/kg milligram(s)/kilogram, 1, 12, hours
Indication: Encephalitis Cytomegalovirus
Start date: 2011-03-06
Ganciclovir
Dosage: see image
Indication: Encephalitis Cytomegalovirus
Start date: 2011-03-06
Ganciclovir
Dosage: see image
Indication: Encephalitis Cytomegalovirus
Start date: 2011-05-18
Ganciclovir
Dosage: 2.5, mg/kg milligram(s)/kilogram, 1, 12, hours
Start date: 2011-03-06
Possible Foscavir side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21
Patient: 69 year old female
Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Pyrexia, Lactic Acidosis, Liver Disorder, Multi-Organ Failure, Epstein-Barr Virus Infection, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
Dosage: 3.5 mg/kg for five days
Indication: Aplastic Anaemia
Start date: 2010-09-15
Foscavir
Dosage: unk ukn, unk
Neoral
Dosage: 200 mg, qd
Administration route: Oral
Indication: Aplastic Anaemia
Start date: 2010-05-01
Other drugs received by patient: Primobolan-Depot INJ; Blood and Related Products; Neupogen
Possible Foscavir side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-17
Patient: 28 year old female
Reactions: Encephalitis Cytomegalovirus
Adverse event resulted in: death
Drug(s) suspected as cause:
Ganciclovir
Start date: 2011-06-03
Ganciclovir
Indication: Encephalitis Cytomegalovirus
Start date: 2011-05-18
Foscavir
Indication: Encephalitis Cytomegalovirus
Start date: 2011-04-20
Foscavir
Start date: 2011-06-03
Possible Foscavir side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-10
Patient: 55 year old male
Reactions: Bronchopulmonary Aspergillosis, Endocarditis Bacterial, Toxic Epidermal Necrolysis, Condition Aggravated, Cholestasis, Multi-Organ Failure, Cytomegalovirus Infection, Febrile Bone Marrow Aplasia, Bilirubin Conjugated Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Gentamicin
Indication: Endocarditis
Start date: 2004-12-22
End date: 2005-01-14
Amoxicillin Trihydrate
Dosage: 2 g, 6xday
Administration route: Oral
Indication: Endocarditis
Start date: 2004-12-22
End date: 2005-01-14
Foscavir
Indication: Cytomegalovirus Infection
Start date: 2004-12-30
End date: 2005-01-14
Fungizone
Indication: Aspergillosis
Start date: 2005-01-04
End date: 2005-01-14
Pantoprazole
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Oesophageal Ulcer
Start date: 2004-12-14
End date: 2005-01-14
Vfend
Administration route: Oral
Indication: Bronchopulmonary Aspergillosis
Start date: 2004-12-30
End date: 2005-01-04
Cymevan
Dosage: 160 mg, 1x/day
Indication: Cytomegalovirus Infection
Start date: 2004-12-14
End date: 2005-01-14
Other drugs received by patient: Prednisone TAB; Pantoprazole; Bactrim
Possible Foscavir side effects in female
Reported by a physician from Finland on 2011-12-29
Patient: female
Reactions: Anaemia, Hepatic Enzyme Increased, Interstitial Lung Disease, Diarrhoea, Staphylococcal Infection, Aspergillosis, Cytomegalovirus Infection, Neutropenia, Blood Creatinine Increased, Sinusitis, Thrombocytopenia, Soft Tissue Neoplasm, Herpes Virus Infection, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Alemtuzumab
Indication: Chronic Lymphocytic Leukaemia
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Valcyte
Administration route: Oral
Indication: Cytomegalovirus Infection
Start date: 2010-04-26
Foscavir
Indication: Cytomegalovirus Infection
Other drugs received by patient: Cyclosporine; Fluconazole; Emgesan; Valtrex; Ratiograstim; Lansoprazole; Prednisone TAB; Neulasta; Ceftazidime; Ribavirin; Hydrocortisone; Gensumycin; Ditrim Duplo; Multitabs; Calcium Carbonate; Adursal; Avelox; Tenox; Ceftriaxone; Mycophenolate Mofetil (Cellcept); Vitamin C; Ceftazidime; Medrol; Pulmicort; Zithromax; Diflucan
Possible Foscavir side effects in 57 year old male
Reported by a physician from France on 2011-12-28
Patient: 57 year old male
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Drug(s) suspected as cause:
Rocephin
Start date: 2011-06-10
End date: 2011-06-11
Flagyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
End date: 2011-06-08
Solu-Medrol
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-08
Foscavir
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
End date: 2011-06-12
Rocephin
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Nozinan (United Kingdom)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-10
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-10
Other drugs received by patient: Acupan; Umuline
Possible Foscavir side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2011-12-27
Patient: 58 year old female
Reactions: Cytomegalovirus Colitis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ganciclovir Sodium
Indication: Cytomegalovirus Colitis
Foscavir
Dosage: intravenous (not otherwise specified)
Possible Foscavir side effects in 24 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-20
Patient: 24 year old female
Reactions: Pancytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Amikacin
Indication: Febrile Convulsion
Start date: 2011-09-09
End date: 2011-01-01
Foscavir
Indication: Cytomegalovirus Infection
Start date: 2011-09-03
End date: 2011-09-09
Vancomycin HCL
Indication: Febrile Convulsion
Start date: 2011-09-09
Primaxin
Indication: Febrile Convulsion
Start date: 2011-09-09
End date: 2011-09-18
Primaxin
Start date: 2011-10-02
Ganciclovir Sodium
Indication: Cytomegalovirus Infection
Start date: 2011-08-30
End date: 2011-09-16
Foscavir
Start date: 2011-09-30
Other drugs received by patient: Piperacillin and Tazobactam; Cancidas; Imuran; Cancidas; Piperacillin and Tazobactam
Possible Foscavir side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-16
Patient: 56 year old male
Reactions: Hyperkalaemia, Anaemia, Disseminated Intravascular Coagulation, Toxic Epidermal Necrolysis, Pancytopenia, Haemodynamic Instability, Haemolysis, Cardio-Respiratory Arrest, Simplex Virus Test Positive, Ventricular Fibrillation, Escherichia Sepsis, Renal Failure Acute, Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Solu-Medrol
Dosage: unk
Start date: 2011-05-30
End date: 2011-06-08
Nozinan
Dosage: unk
Start date: 2011-06-07
End date: 2011-06-10
Nexium
Dosage: unk
Start date: 2011-05-30
End date: 2011-06-10
Foscavir
Dosage: unk
Start date: 2011-06-01
End date: 2011-06-11
Rocephin
Dosage: unk
Start date: 2011-05-29
End date: 2011-06-08
Rocephin
Dosage: unk
Start date: 2011-06-10
End date: 2011-06-11
Flagyl
Dosage: unk
Start date: 2011-05-29
End date: 2011-06-08
Other drugs received by patient: Prednisone TAB; Acupan; Umuline
Possible Foscavir side effects in 57 year old male
Reported by a physician from France on 2011-12-16
Patient: 57 year old male
Reactions: Toxic Epidermal Necrolysis
Adverse event resulted in: death
Drug(s) suspected as cause:
Rocephin
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
End date: 2011-06-11
Solu-Medrol
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-08
Nozinan (United Kingdom)
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-10
Rocephin
Start date: 2011-06-10
End date: 2011-06-11
Flagyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
End date: 2011-06-08
Nexium
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-10
Foscavir
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-01
End date: 2011-06-11
Other drugs received by patient: Acupan; Umuline
Possible Foscavir side effects in 58 year old female
Reported by a physician from Czech Republic on 2011-12-08
Patient: 58 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Cytomegalovirus Colitis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ganciclovir Sodium
Indication: Cytomegalovirus Colitis
Foscavir
|